Atlas Trials

A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor

Clinical trial NCT01063946 · COMPLETED

Trial details

NCT number
NCT01063946
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms, Malignant
Start date
2010-01-01
Primary completion
2011-03-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.